Results 91 to 100 of about 4,446,831 (170)

Impact of Cisplatin on Hearing: Analysis Using PTA, High‐Frequency Audiometry, DPOAE, and Speech‐in‐Noise Test

OTO Open
Objective To assess hearing loss in patients with cancer receiving cisplatin‐based chemotherapy using high‐frequency pure tone average (HFPTA), distortion product otoacoustic emissions (DPOAEs), and the speech‐in‐noise (SPIN) test, and to identify ...
Juhi Irfana Basheer, Ramaswamy Balakrishnan, Poorvi V. Sharma, Madikeri Mohan Kishan, Karthik Udupa   +4 more
doaj   +1 more source

In vivo screening for toxicity-modulating drug interactions identifies antagonism that protects against ototoxicity in zebrafish

Frontiers in Pharmacology
Introduction: Ototoxicity is a debilitating side effect of over 150 medications with diverse mechanisms of action, many of which could be taken concurrently to treat multiple conditions.
Ethan Bustad, Emma Mudrock, Elizabeth M. Nilles, Andrea Mcquate, Andrea Mcquate, Andrea Mcquate, Monica Bergado, Alden Gu, Louie Galitan, Natalie Gleason, Henry C. Ou, Henry C. Ou, David W. Raible, David W. Raible, David W. Raible, Rafael E. Hernandez, Rafael E. Hernandez, Shuyi Ma, Shuyi Ma, Shuyi Ma, Shuyi Ma   +20 more
doaj   +1 more source

Preventing, Monitoring, and Managing Ototoxicity Related to Cisplatin: Proactive Rather Than Reactive Approaches Are Needed.

JCO Oncology Practice, 2023
N. Mohindra
semanticscholar   +1 more source

Ototoxicity: Early Detection and Monitoring

The ASHA Leader, 2005
Dawn Konrad-Martin, Wendy J. Helt, Kelly M. Reavis, Jane S. Gordon, Laura L. Coleman, Gene W. Bratt, Stephen A. Fausti   +6 more
openaire   +1 more source

Cancer therapy-induced ototoxicity: Current challenges and emerging management strategies. [PDF]

Animal Model Exp Med
Huang Y, Xu B, Chen X, Chen Y, Yu D.
europepmc   +1 more source

Progressive Sensorineural Hearing Loss Following Cisplatin Chemotherapy: Mechanisms Underlying Cochlear Retention and Long-Term Ototoxicity. [PDF]

Pharmaceuticals (Basel)
Ruggiero A, Picciotti PM, Mastrangelo S, Romano A, Talloa D, Galli J, Attinà G.   +6 more
europepmc   +1 more source

Effectiveness of medical interventions implemented during ototoxicity monitoring to prevent further deterioration of hearing thresholds

, 2015
Hlupheka M. Maluleka, S. Kuschke, L. Ramma, S. Mashele, Matsie M. Ntatamala, Tracy A. Frosler, Ezethu B. Potelwa, Dylan Walker   +7 more
semanticscholar   +1 more source

Early Detection of Ototoxicity Using Serial Mobile Audiometry, Otoacoustic Emissions Testing, and Inner Ear Biomarker Measurement in Patients Receiving Platinum-Based Chemotherapy Treatment: It is Feasible to Implement in a National Health Service (NHS) Cancer Ambulatory Care Setting. [PDF]

Otol Neurotol
Mehta N, Awad A, Forbes M, Iliadou E, Katiri R, Ferdous T, Lowe H, Ensell L, Alifrangis C, Schilder AGM, Windsor R.   +10 more
europepmc   +1 more source

Identifying Gaps and Opportunities to Improve Ototoxicity Management in Veterans With Cancer: Evidence From a Retrospective Cohort and Oncology Provider Survey. [PDF]

Cancer Med
Lacey C, Clark K, Debacker JR, Stuehm H, Hungerford M, Milnes T, Johansson K, Mannino R, Graff JN, Konrad-Martin D.   +9 more
europepmc   +1 more source

The synergistic ototoxicity of adalimumab combined with methotrexate in the treatment of ankylosing spondylitis. [PDF]

Front Neurol
Wei H, Xu C.
europepmc   +1 more source